tavi

All you need to know about the 2018 Perú Sessions

After more than 3 years, SOLACI returns to Lima to carry out the XXXVI edition of the Regional SOLACI Sessions. As always, for SOLACI it implies a great motivation and a stimulating challenge to continue promoting the development of interventional cardiology in Latin American. Are you planning on participating in the next 2018 Perú Sessions?...

Análisis de laboratorio sencillos para estratificar mejor el bajo flujo y bajo gradiente

Simple Lab Tests to Better Stratify Low Flow and Low Gradient AS Patients

Combining B-type natriuretic peptide (BNP) and high-sensitive cardiac troponin T measures undeniably helps to better stratify severe aortic stenosis patients with low flow and low gradient.  Many patients in these conditions clearly benefit from a transcatheter aortic valve replacement (TAVR) procedure, and for others it is simply useless, and given its high cost, better stratification...

See the presentations of the 9th José Gabay Fellow Course

We are deeply thankful to all interventional physicians who, motivated by their great scientific and educational vocation, presented their works at the “José Gabay” Course. Read the presentations below:   Module I: Fundamentals and Basic Elements. Leiva Pons, José Luis. “Vascular Closure Devices. Step by Step.”   (Spanish version) García García, Hector. “Current Status of Coronary Intervention:...

FUTURE: una piedra en el zapato para el FFR y más preguntas que respuestas

ESC 2018 | FUTURE: A Thorn in FFR and More Questions than Answers

As observed at the preliminary analysis that motivated the FUTURE trial early termination, the use of fractional flow reserve (FFR) to guide revascularization in an unselected population with multivessel disease was associated to twice the mortality rate in one year, with no beneficial impact on other end points. Even though the combined end point of...

Enfermedades malignas y estenosis aórtica ¿Se justifica el TAVI?

Gradient vs. Flow to Determine Aortic Valve Stenosis Severity before and after TAVR

Pressure loss vs. flow curves offer a fundamental synthesis of fluids dynamics in describing aortic valve physiopathology. Severe aortic stenosis is not just an orifice (as suggested by Gorlin) or a segment that offers dynamic resistance. However, once a new transcatheter valve has been implanted, it will behave purely as a resistor. At dobutamine dose,...

Mujeres en Cardiología: Todavía subrepresentadas en una especialidad llena de hombres

Women in Cardiology: Still Underrepresented in a Field Full of Men

JAMA Cardiology dedicated a special with 4 articles on different issues women continue to face when considering this area of expertise, or when they have already chosen this fascinating field but still feel undervalued or discriminated compared with their male colleagues. One of the studies showed the career preferences of med school students. What trainees...

¿Cómo clasificar la estenosis aórtica de los pacientes que recibieron TAVI?

More Favorable Evidence for TAVR in Severe Aortic Regurgitation

Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) was developed for aortic stenosis, but there is a significant number of patients with severe aortic regurgitation who still undergo this procedure as an off-label indication. Current evidence for this procedure in relation with this disease is growing, mainly due to good results obtained by different...

Descubra las sesiones conjuntas del Congreso SOLACI-SOCIME 2018

Discover the International Joint Sessions of the SOLACI-SOCIME 2018 Congress

Once again, the most relevant scientific societies in the world have trusted SOLACI Congress to debate different topics on interventional cardiology, and so we have put together different joint sessions tailored to your interests, to be presented by the most prestigious faculty members in the world. Next, see what joint sessions you will be able...

Top